Innovative Biotech Initiatives in Russian Oncology and Immunology 2020
Explore the latest biotech startups and scientific endeavors in oncology and immune inflammatory fields in Russia for 2020. Discover potential indications, development stages, modalities, targets, pathways, IP strategies, validation levels, and team competences.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
Scouting for Servier t Best biotech startups and scientific initiatives in oncology and immune inflammatory in Russia 2020
Name of the project Legal entity name or Institute name Summary of opportunity (abstract format) Potential Indication (if applicable) and project development stage Modality (small molecule, antibody(human/humanized)
Target and MoA Legal entity name or Institute name Target and rationale in disease (be precise; if not, precise if available under CDA or if not determined) Pathway Mode of Action
IP protection and strategy Legal entity name or Institute name Patent(s) granted/Patent application(s) If listed, please add 1stapplication date(s)
In vitro and In vivo validation Legal entity name or Institute name Level of in-vitro target validation (binding assay, activity in cell line models, activity in ex-vivo systems, ADME) Level of in vivo target validation (efficacy in vivo (target engagement), ADME, PD/PK, toxicity, evidence in knock- in/knock-out animal models).
Team and Competences Legal entity name or Institute name Team (who contributes 100% of his/hers time to project) and contacts
